Welcome to our dedicated page for DPLSD news (Ticker: DPLSD), a resource for investors and traders seeking the latest updates and insights on DPLSD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DPLSD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DPLSD's position in the market.
DarkPulse (OTCQB: DPLS) announced on December 18, 2025 a nonexclusive, royalty-bearing Patent and Trademark License Agreement with UMBRA Technologies to use UMBRA’s U.S. patent portfolio, know-how, and trademarks for monitoring critical infrastructure with DarkPulse’s BOTDA distributed fiber-optic sensors.
The license covers UMBRA patents including U.S. Patent No. 10,630,505 and the Slingshot family, permits U.S.-limited broader rights, and allows future exclusivity "carve-outs" tied to additional royalties. The firms plan to integrate UMBRA’s secure GVN/Slingshot networking with DarkPulse’s high-resolution sensing for encrypted, low-latency global data delivery.
